GSPT2, SAMD4A, and TIPARP are downregulated in ECM-receptor interaction pathways, which play important roles in tumor shedding, adhesion, degradation, motility, and proliferation and may be involved in breast cancer development (Bao et al., 2019). Here, SAMD4A is linked to breast carcinoma.